Second attempt: Curevac is pushing ahead with corona vaccine plans

Second attempt Curevac is pushing ahead with corona vaccine plans 02/12/2022, 2:11 p.m In the first attempt, Curevac failed with the development of a corona vaccine. Now the Tübingen-based company wants to advance a second-generation vaccine: “It can’t be that a booster vaccination should be necessary every three months,” says Curevac boss Haas. The Tübingen … Read more

Biotech company from Munich plans to go public on the Nasdaq

Radionuclide-Krebstherapie ITM has been producing radioisotopes for pharmaceutical companies around the world since the company was founded. (Photo: ITM) Frankfurt The Munich-based company ITM, which specializes in cancer therapy, is planning an IPO on the Nasdaq, according to financial circles. The biotech firm could be valued at $ 1 to $ 1.5 billion on listing, … Read more

The future depends on technological breakthroughs

Disruption Ten trends in technology, careers, and finance are set to change our lives fundamentally. (Photo: Thomas Kuhlenbeck) Virtual worlds, cells modified with the help of AI and high-tech against climate change: We show how new technologies and life merge. Downward wage spiral, virtual offices, hardly any hierarchies – how the changes in our working … Read more

Curevac increases sales strongly – loss also increases significantly

Curevac The biotech company can significantly increase its sales. (Photo: dpa) Tübingen The biotech company Curevac significantly increased its losses in the third quarter with a sharp rise in sales. The company announced on Thursday evening in Tübingen that sales rose by 463 percent to 29.3 million euros compared to the same period last year. … Read more

CureVac canceled its first vaccine project: what will happen to the 29 mlls. dose that you negotiated with Peru? | nndc coronavirus | PERU

The German laboratory CureVac announced the cancellation of the development of its first vaccine against COVID-19 due to its unsatisfactory results. According to the firm, it is now going to “focus on the development of a vaccine against COVID-19 second generation ”, and therefore will“ withdraw ”its current project from the procedures of the European … Read more

German Pharmaceutical Curevac Waives Its Covid-19 Vaccine

A nurse, during the clinical trial of the German vaccine Curevac, at the Hospital de Cruces in Bilbao. EP After more than a year of research and clinical trials, the German pharmacist Curevac renounces the development of their vaccine against Covid-19. As the company announced on Tuesday, its first formula designed against the coronavirus is … Read more